RAMSAY DAVID A — SEC Form 4 filings

SEC reporting owner CIK 1283292. 7 Form 4 filings on record with FilingPulse; latest filed 2026-07-02.

Transaction summary — filings shown

Covers all 7 filings on record, filed 2024-11-18 to 2026-07-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Savara Inc (SVRA)Director52 legs · 250,000 sh · $703,8501 leg · 20,000 sh · $121,2202
HALOZYME THERAPEUTICS, INC. (HALO)EVP, PRESIDENT, DRUG DELIVERY26

Form 4 filings — RAMSAY DAVID A

FiledFormIssuerReported transactionsSource
2026-07-024HALOZYME THERAPEUTICS, INC. (HALO)Option exercise (M): 10,000 @ $0 · Tax withholding (F): 5,408 @ $78.27 · Option exercise (M): 10,000 (derivative) @ $0 · Grant/award (A): 16,232 (derivative) @ $0 · Grant/award (A): 39,823 (derivative) @ $0EDGAR
2026-04-024HALOZYME THERAPEUTICS, INC. (HALO)Grant/award (A): 10,000 (derivative) @ $0EDGAR
2025-12-194Savara Inc (SVRA)Sale (S): 20,000 @ $6.06EDGAR
2025-12-114Savara Inc (SVRA)Grant/award (A): 40,000 @ $0EDGAR
2025-04-014Savara Inc (SVRA)Purchase (P): 150,000 @ $2.77EDGAR
2024-12-164Savara Inc (SVRA)Grant/award (A): 40,000 @ $0EDGAR
2024-11-184Savara Inc (SVRA)Purchase (P): 100,000 @ $2.88EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1283292 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →